Kava Pyrones and Resin: Studies on GABAA, GABAB and Benzodiazepine Binding Sites in Rodent Brain
The DOI matches its Crossref record.
Abstract
Kava, an intoxicating beverage prepared from the pepper plant Piper methysticum, is widely consumed by the indigenous peoples in the islands of the South Pacific. As the first of a series of studies on the neuropharmacological interactions of kava with CNS receptors we tested purified pyrones and kava resin for activity on GABA and benzodiazepine binding sites in rat and mouse brain membranes. Only weak activity was observed on GABA A binding sites in washed synaptosomal membranes prepared from rat brain and this was abolished by extraction of the membranes with Triton X‐100, suggesting that lipid soluble components were involved. No effects were observed on GABA a binding sites in rat brain membranes in vitro. Kava resin and pyrones exerted some weak effects on benzodiazepine binding in vitro but this did not correlate with pharmacological activity. In addition, in ex vivo studies, no effects were observed on [3 H]diazepam binding to brain membranes prepared from mice in which selected kava constituents were injected intraperitoneally, whereas similarly administered diazepam (5 mg/kg) inhibited [3 H]diazepam binding by >95%. Similar lack of activity was observed in in vivo binding studies; injection of kava resin failed to influence the CNS binding of the benzodiazepine‐receptor ligand [3 H]Ro15‐1788 injected into mice prior to sacrifice. The pharmacological activities of kava resin and pyrones do not appear to be explained by any significant interaction with GABA or benzodiazepine binding sites.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Miller, L. G. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.20.2200 · Cited by 809
Sarris, J., Panossian, A., Schweitzer, I., Stough, C., & Scholey, A. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.04.002 · Cited by 469
Efficacy of Kava Extract for Treating Anxiety: Systematic Review and Meta-Analysis
Pittler, M. H., & Ernst, E. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200002000-00014 · Cited by 267
Herbal medicines in the treatment of psychiatric disorders: a systematic review
Sarris, J. (2007) · Phytotherapy Research · doi:10.1002/ptr.2187 · Cited by 164
“21, 703–716 (2007) DOI: 10.1002/ptr The exact pharmacodynamic mechanism responsible for kava’s action is still undefined, with conflicting evidence regarding the modulation of various GABA receptors (Davies et al., 1992; Jussofie et al., 1994; Yuan et al., 2002).”
BackgroundInfluentialGABA-modulating phytomedicines for anxiety: A systematic review of preclinical and clinical evidence
Savage, K., Firth, J., Stough, C., & Sarris, J. (2018) · Phytotherapy Research · doi:10.1002/ptr.5940 · Cited by 131
Metadata
- Authors
- Davies, L. P., Drew, C. A., Duffield, P., Johnston, G. A. R., & Jamieson, D. D.
- Venue
- Pharmacology & Toxicology
- Publisher
- Wiley
- Published
- 1992-08
- Volume
- 71
- Issue
- 2
- Pages
- 120-126
- ISSN
- 0901-9928 (ISSN-L)
- OpenAlex
- W2023166957
- Cited by
- 110
- References
- 0
- FWCI
- 0.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Kava Pyrones and Resin: Studies on GABAA, GABAB and Benzodiazepine Binding Sites in Rodent Brain. https://app.cochat.ai/papers/10.1111/j.1600-0773.1992.tb00530.x
- The paper
- Davies, L. P., Drew, C. A., Duffield, P., Johnston, G. A. R., & Jamieson, D. D. (1992). Kava Pyrones and Resin: Studies on GABAA, GABAB and Benzodiazepine Binding Sites in Rodent Brain. Pharmacology & Toxicology. https://doi.org/10.1111/j.1600-0773.1992.tb00530.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.